Medical Cannabis Interactions with Medications: UK Guide

Medical Cannabis and Drug Interactions: What UK Patients Need to Know

As medical cannabis becomes increasingly prescribed across the UK, understanding how it interacts with other medications is critical for patient safety. Both CBD and THC affect the body's drug metabolising enzymes — meaning cannabis can change how other medications work in your system.

This guide explains the mechanisms behind cannabis drug interactions, lists the most clinically significant interactions, and explains what steps to take if you are on multiple medications. You can also use our drug interaction checker for personalised guidance.

How Cannabis Interacts with Medications: The CYP450 System

The primary mechanism of cannabis drug interactions is through the cytochrome P450 (CYP450) enzyme system — a family of liver enzymes responsible for metabolising the majority of prescription medications.

CBD is a particularly potent inhibitor of CYP3A4 and CYP2C19, two of the most important metabolising enzymes. When these enzymes are inhibited, affected drugs are metabolised more slowly, leading to higher drug concentrations in the blood — effectively increasing their dose and, potentially, their toxicity.

THC inhibits CYP2C9 and CYP2C19 to a lesser degree, though the interaction is still clinically significant for certain medications.

High-Priority Drug Interactions

Anticoagulants (Blood Thinners)

Cannabis — particularly CBD — significantly increases blood levels of warfarin by inhibiting CYP2C9-mediated metabolism. This can increase the risk of bleeding. If you are prescribed warfarin, more frequent INR monitoring is essential if starting or changing medical cannabis. The same caution applies to apixaban, rivaroxaban, and other novel oral anticoagulants.

Anti-Epilepsy Medications

CBD is itself an approved anti-epilepsy treatment (Epidiolex), but it interacts with several other anti-epileptic drugs:

• Clobazam: CBD inhibits the CYP enzymes that metabolise clobazam, leading to elevated levels and potential sedation or toxicity.
• Valproate: Combined use can increase liver enzyme elevation risk.
• Topiramate, Zonisamide: Elevated levels possible with CBD co-administration.

If you use anti-epileptic medications, your neurologist should review your full medication list when prescribing cannabis. Learn more about medical cannabis for epilepsy in the UK.

Antidepressants and Psychiatric Medications

• SSRIs/SNRIs (fluoxetine, sertraline, venlafaxine): CBD can inhibit CYP2D6 metabolism of some SSRIs. Monitoring for increased side effects such as serotonin syndrome risk is advisable.
• Antipsychotics (quetiapine, olanzapine): THC may antagonise antipsychotic effects and worsen psychotic symptoms in susceptible individuals. CBD may mitigate this to some degree, but caution is warranted.
• Lithium: No direct enzyme interaction, but THC-induced dehydration can elevate lithium levels.

Immunosuppressants

Tacrolimus, cyclosporine, and sirolimus are metabolised by CYP3A4 and CYP3A5. CBD inhibition of these enzymes can significantly raise blood levels, increasing toxicity risk. Transplant patients should exercise particular caution and inform their transplant team.

Benzodiazepines and Sedatives

CBD and THC both potentiate CNS depression. Combined use with benzodiazepines (diazepam, lorazepam, temazepam), Z-drugs, or opioids can cause excessive sedation, respiratory depression, and cognitive impairment. Discuss any existing sedative prescriptions with your cannabis doctor.

Statins

Several statins including atorvastatin and simvastatin are metabolised by CYP3A4. CBD inhibition can increase statin blood levels, raising the risk of muscle toxicity (myopathy). Pravastatin and rosuvastatin are generally safer alternatives with lower interaction risk.

Metformin and Diabetes Medications

Cannabis can affect blood glucose levels. THC may cause transient blood sugar changes, and CBD may improve insulin sensitivity. Patients on metformin, insulin, or other diabetes medications should monitor blood glucose more closely when starting cannabis treatment.

Less Common but Notable Interactions

• Beta-blockers (metoprolol, propranolol): CBD may increase blood levels slightly. Monitor blood pressure.
• Calcium channel blockers (amlodipine, diltiazem): CYP3A4 inhibition may increase levels.
• Proton pump inhibitors (omeprazole): CBD inhibits CYP2C19, potentially elevating levels.
• Codeine and tramadol: CYP2D6 inhibition by CBD may reduce conversion to active metabolites, potentially reducing efficacy.

What to Do If You Take Multiple Medications

1. Provide a complete medication list to your cannabis prescribing clinic before your consultation.
2. Inform your GP that you have been prescribed medical cannabis — they can check for interactions with your full medication record.
3. Use the LeafMe drug interaction checker as a starting point for research.
4. Request more frequent monitoring (blood tests, INR checks) when starting cannabis treatment if you are on high-risk medications.
5. Never adjust other medications based on suspected cannabis interactions without medical guidance.

Summary

• CBD is a significant inhibitor of CYP3A4 and CYP2C19 — affecting metabolism of many common medications.
• Highest risk interactions: warfarin, anti-epileptics, immunosuppressants, benzodiazepines, and some statins.
• Always disclose your full medication list to your cannabis prescriber and GP.
• Use the drug interaction checker and review our side effects guide for complementary information.